Target intelligence / Profile preview

Multiple cytokines

Molecular classification
Other (Cytokines; a large heterogeneous family of secreted signaling proteins and glycoproteins; includes no single unifying molecular family)
01

Overview

Cytokines are a large, diverse family of secreted signaling proteins and glycoproteins released primarily by immune cells to mediate intercellular communication, regulate immunity, inflammation, hematopoiesis, tissue repair, and homeostasis. They act through high-affinity cell surface receptors, initiating intracellular signaling cascades such as JAK/STAT and NF-κB to modulate gene expression and cellular responses. Dysregulation of cytokine networks is linked to a range of diseases including inflammation, cancer, infection, and autoimmune disorders. Because "multiple cytokines" refers collectively to this entire class, it is not a precise drug target; rather, individual cytokines (like interleukin-6, tumor necrosis factor alpha, or interferon gamma) are specific and actionable molecular targets in research and therapy.

Other names
CytokinesImmune cytokinesSignaling cytokinesInflammatory cytokinesSoluble mediators
02

Mechanism of action

Inhibition of cytokine production or signaling (e.g., JAK/STAT inhibitors, anti-cytokine antibodies); Cytokine receptor blockade; Immunomodulation via regulation of cytokine expression or release

03

Biological functions

Immune responseRegulation of inflammationCell signalingCellular proliferation and differentiationHematopoiesisCell survival and deathTissue homeostasisInduction or suppression of feverPain modulation
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionCytokine release syndromeImmunodeficiencySepsisOther (multiple system involvement)
05

Safety considerations

Cytokine modulation can trigger immunosuppressionCytokine release syndrome (CRS) is a serious, potentially life-threatening complication of therapies that stimulate broad cytokine secretionIncreased risk of infections, malignancy, or autoimmune complications when cytokine networks are broadly targeted
06

Interacting drugs

Too broad to list; drugs interact with specific cytokines (e.g., anti-TNF drugs, IL-6 inhibitors, interferons, colony-stimulating factors), but none interact with "multiple cytokines" as a collective target

1 more in the full profile.

07

Biomarkers

Serum/plasma levels of individual cytokines are frequently measured, e.g., IL-6, TNF-α, IL-1β, IFN-γ, as diagnostic or prognostic biomarkersCytokine profiles ("cytokine panels") are often assessed to guide therapy in diseases like sepsis, COVID-19, and autoimmune disorders

Beyond the preview

Go deeper on Multiple cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call